載入...
CYP46A1-dependent and independent effects of efavirenz treatment
Cholesterol excess in the brain is mainly disposed via cholesterol 24-hydroxylation catalysed by cytochrome P450 46A1, a CNS-specific enzyme. Cytochrome P450 46A1 is emerging as a promising therapeutic target for various brain diseases with both enzyme activation and inhibition having therapeutic po...
Na minha lista:
| 發表在: | Brain Commun |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713991/ https://ncbi.nlm.nih.gov/pubmed/33305262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcaa180 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|